EBR to Raise A$150m via Fully Underwritten Capital Raising

• EBR Systems plans to raise A$150m via a fully underwritten capital raising
• Includes institutional placement and entitlement offer
• Funds will support sales, manufacturing, R&D, and working capital
• Existing securityholders committed to $46.65m
• Entitlement offer open to eligible securityholders

EBR Systems, Inc. has announced a fully underwritten capital raising of A$150m, comprising an institutional placement and an entitlement offer. The institutional placement, including Tranche 1 and Tranche 2, aims to raise A$64.4m, with Tranche 2 subject to securityholder approval. The entitlement offer will raise approximately A$85.6m and is open to eligible securityholders, including institutional and retail investors. The proceeds will fund sales and marketing expansion, manufacturing scale-up, R&D, clinical activities, working capital, and offer costs. Certain existing securityholders have committed to A$46.65m, including a A$35.0m placement and sub-underwriting the retail component. EBR's WiSE System was successfully implanted in 41 patients in Q1 2026, and the company has secured purchase agreements with major US healthcare providers.

EBR Systems plans to raise A$150m to fund operations through to cashflow breakeven.

EBR Systems aims to use the raised funds to support its growth initiatives, including sales and marketing expansion, manufacturing scale-up, R&D, and clinical activities.